Revelation Biosciences, Inc. (REVB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.88
- As of
Kresmion compiles this page from REVB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
REVELATION BIOSCIENCES, INC. (REVB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-13.
See the full REVB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for REVB on one page. Preview it with sample data, then open it live with a free account.
Preview the REVB dossierActive events for REVB
- mediumEarnings above estimates
Q3-2026: Beat consensus by 5.8%, EPS $-5.92 vs $-6.2832 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in REVB
- mediumEarnings below estimates
Q1-2026: Missed consensus by 131.0% - EPS $-2.71 vs $-1.173 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 54.3% - EPS $-28.04 vs $-18.1764 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 30.0% - EPS $-7.08 vs $-5.4468 estimate
FREE, NO ACCOUNT
Every event on REVB, as it fires
You are seeing 5 of 7 events recorded on REVB since 2026-05-26.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, REVB
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
REVB's 10-Q filed Nov 5, 2026 states:
…which raises substantial doubt about its ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on REVB
REVB against its peers
REVB's return on equity of -100.6% ranks in the 68th percentile of 16 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.
| Metric | REVB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 359700 | n/a | 9 |
| Gross margin | n/a | 77.6% | n/a | 9 |
| Operating margin | n/a | -3270.0% | n/a | 10 |
| Net margin | n/a | -3189.7% | n/a | 10 |
| Return on equity | -100.6% | -212.6% | 68 | 16 |
| 1 year | n/a | -91.1% | n/a | 14 |
Peers (20): VIVS, HCWB, CASIF, APVO, SLXN, PPBT, CLDI, ONCO, BRTX, ACUT, DCOY, LSBCF.D, CMND, SXTP, JUNS, SILO, EOCN, PPCB, ERNA, MBIO. Left out: AGNPF (no annual filing), GPLL (period gap), BIXT (no annual filing), VCNX (period gap), NYMXF (period gap). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (REVB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in REVB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on REVB in the last 180 days.
Upstream: SEC EDGAR filings for REVB
Kresmion, "REVELATION BIOSCIENCES, INC. (REVB) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/REVB. Upstream data: SEC EDGAR filings for REVB.
Link to this data (HTML):
<a href="https://kresmion.com/research/REVB">REVELATION BIOSCIENCES, INC. (REVB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow REVB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to REVB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.